CXCR3 and Cognate Ligands are Associated with Immune Cell Alteration and Aggressiveness of Pancreatic Ductal Adenocarcinoma.

Andrew Cannon Christopher M Thompson Hans Carlo Maurer Pranita AtriRakesh BhatiaSean WestDario GhersiKenneth P OliveSushil KumarSurinder K Batra

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

CXCR3 ligands are overexpressed in PDAC and are associated with poor survival likely related to alterations in tumor immune infiltrate/activity.

Keyphrases